Prospective multicenter clinical observational study of conversion rate of hydromorphone in cancer patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040230173

Enrollment

Registered

2024-03-20

Start date

2024-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inpatient switching from injectable to oral formulations of hydromorphone

Exclusion criteria

Exclusion criteria: Concomitant use of opioids other than hydromorphone

Design outcomes

Primary

Measure	Time frame
Conversion rate of hydromorphone	—

Contacts

Public ContactKazuyo Nakamura

Shizuoka General Hospital

kazuyo-nakamura@i.shizuoka-pho.jp+81-54-247-6111

Outcome results